Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $23.8M | $31.8M |
| Revenue growth | — | — | — | — | 33.9% |
| Operating income | — | -$1.78M | -$3.73M | -$2.92M | — |
| Operating margin | — | — | — | -12.3% | — |
| Net income | — | $1.12M | $4.44M | -$65.1M | -$69.6M |
| Net margin | — | — | — | -274.0% | -218.9% |
| EPS (diluted) | — | — | — | -$11.15 | -$1.65 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | — | -$1.70M | -$5.08M | -$3.31M | -$16.1M |
| Share buybacks | — | — | $96.8M | $117M | — |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $1.23M | $72.8K | $1.49M | $18.3M | $7.65M |
| Total assets | $225M | $256M | $166M | $126M | $153M |
| Total liabilities | $8.95M | $10.4M | $4.55M | $193M | $90.5M |
| Shareholders' equity | -$5.98M | -$8.50M | -$8.43M | -$67.8M | $63.0M |
| Retained earnings | -$5.98M | -$8.50M | -$11.3M | -$101M | -$171M |
| Shares (wtd avg diluted) | — | — | — | 5.84M | 42.2M |
Every figure is extracted from Fold Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.